Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Osteoporosis Reports
Published in: Current Osteoporosis Reports 4/2014

01-12-2014 | Therapeutics and Medical Management (E Shane and RA Adler, Section Editors)

Osteoporosis Diagnosis in Men: The T-Score Controversy Revisited

Authors: Neil Binkley, Robert Adler, John P. Bilezikian

Published in: Current Osteoporosis Reports | Issue 4/2014

Login to get access

Abstract

Osteoporosis becomes common with aging in both sexes, but is often ignored in men. The 2013 International Society for Clinical Densitometry consensus conference endorsed a Caucasian female referent database for T-score calculation in men. This recommendation has generated controversy and concern. Accumulating data indicate that at the same DXA-measured body mineral density (BMD) (g/cm2), men and women are at approximately the same fracture risk. With this point in mind, using the same database to derive the T-score in men and women is reasonable. As a result, a greater proportion of men who sustain a fragility fracture will have T-scores that are higher than they would if a male database were used; in fact, many men will fracture at T-scores that are “normal.” This highlights the importance of diagnosing osteoporosis not just by T-score, but also by the presence of fragility fracture and/or by estimations of fracture risk as generated by tools such as the FRAX calculator. The practical consequences of this change in densitometric definition of osteoporosis in men should be monitored, including the proportion of men at risk identified and treated as well as defining the response to treatment in those assessed by this more comprehensive approach.
Literature
1.
Anonymous. Osteoporosis prevention, diagnosis and therapy NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy. JAMA. 2001;285:785–95.
2.
3.
Bliuc D, Nguyen ND, Milch VE, et al. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009;301:513–21.PubMedCrossRef
4.
Watts NB, Adler RA, Bilezikian JP, et al. Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:1802–22.PubMedCrossRef
5.
Amin S, Achenbach SJ, Atkinson EJ, et al. Trends in fracture incidence: a population-based study over 20 years. J Bone Miner Res. 2014;29:581–9.PubMedCrossRef
6.
7.
Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2007;22:465–75.PubMedCrossRef
8.
9.
Orwoll ES, Ettinger M, Weiss S, et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med. 2000;343:604–10.PubMedCrossRef
10.•
Boonen S, Reginster JY, Kaufman JM, et al. Fracture risk and zoledronic acid therapy in men with osteoporosis. N Engl J Med. 2012;367:1714–23. This is the first therapeutic study in men with fracture as the primary outcome. Zoledronic acid reduced morphometric vertebral fractures in men, compared with placebo. PubMedCrossRef
11.
Solomon DH, Johnston SS, Boytsov NN, et al. Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011. J Bone Miner Res. 2014;29(9):1929-1937
12.
Watts NB, Leslie WD, Foldes AJ, et al. 2013 International Society for Clinical Densitometry Position Development Conference: Task Force on Normative Databases. J Clin Densitom. 2013;16:472–81.PubMedCrossRef
13.
14.
Anonymous. Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis WHO Technical Report Series 843. World Health Organization. 1994.
15.
Watts NB. Using bone mineral density T-scores to diagnose postmenopausal osteoporosis. Endocr Pract. 2000;6:217–8.PubMedCrossRef
16.
Faulkner KG, Roberts LA, McClung MR. Discrepancies in normative data between Lunar and Hologic DXA systems. Osteoporos Int. 1996;6:432–6.PubMedCrossRef
17.
Steiger P. Letter to the editor standardization of spine BMD measurements. J Bone Miner Res. 1995;10:1602–3.CrossRef
18.
Hanson J. Letter to the editor; standardization of femur BMD. J Bone Miner Res. 1997;8:1316–7.CrossRef
19.
Binkley N, Schmeer P, Wasnich RD, et al. What are the criteria by which a densitometric diagnosis of osteoporosis can be made in males and non-Caucasians? J Clin Densitom. 2002;5(Suppl):S19–27.PubMedCrossRef
20.
21.
Hans PDD, Downs RW, Duboeuf F, et al. Skeletal sites for osteoporosis diagnosis: The 2005 ISCD Official Positions. J Clin Densitom. 2006;9:15–21.PubMedCrossRef
22.
Ross PD, Lombardi A, Freedholm D. The assessment of bone mass in men. In: Orwoll ES, editor. Osteoporosis in men: The effects of gender on skeletal health. San Diego: Academic Press; 1999. p. 505–25.CrossRef
23.
De Laet CEDH, Van Hout BA, Burger H, et al. Hip fracture prediction in elderly men and women: validation in the Rotterdam study. J Bone Miner Res. 1998;13:1587–93.PubMedCrossRef
24.
Cheng S, Suominen H, Sakari-Rantala R, et al. Calcaneal bone mineral density predicts fracture occurrence: a five-year follow-up study in elderly people. J Bone Miner Res. 1997;12:1075–82.PubMedCrossRef
25.
De Laet CE, van Hout BA, Burger H, et al. Bone density and risk of hip fracture in men and women: cross sectional analysis. Br Med J. 1997;315:221–5.CrossRef
26.
The EuropeanProspective Osteoporosis Study (EPOS) Group Authors. The relationship between bone density and incident vertebral fracture in men and women. J Bone Miner Res. 2002;17:2214–21.
27.
Langsetmo L, Leslie WD, Zhou W, et al. Using the same bone density reference database for men and women provides a simpler estimation of fracture risk. J Bone Miner Res. 2010;25:2108–14.PubMedCrossRef
28.
Leslie WD, Langsetmo L, Zhou W, et al. Choice of lumbar spine bone density reference database for fracture prediction in men and women: a population-based analysis. J Clin Densitom. 2014;17:295–300.PubMedCrossRef
29.
Selby PL, Davies M, Adams JE. Do men and women fracture bones at similar bone densities? Osteoporos Int. 2000;11:153–7.PubMedCrossRef
30.
Cauley JA, Zmuda JM, Wisniewski SR, et al. Bone mineral density and prevalent vertebral fractures in men and women. Osteoporos Int. 2004;15:32–7.PubMedCrossRef
31.
Riggs BL, Melton LJI, Robb RA, et al. Population-based study of age and sex differences in bone volumetric density, size, geometry and structure at different skeletal sites. J Bone Miner Res. 2004;19:1945–54.PubMedCrossRef
32.
Gilsanz V, Boechat MI, Gilsanz R, et al. Gender differences in vertebral sizes in adults: biomechanical implications. Radiology. 1994;190:678–82.PubMedCrossRef
33.
Looker AC, Beck TJ, Orwoll ES. Does body size account for gender differences in femur bone density and geometry? J Bone Miner Res. 2001;16:1291–9.PubMedCrossRef
34.••
Srinivasan B, Kopperdahl DL, Amin S, et al. Relationship of femoral neck areal bone mineral density to volumetric bone mineral density, bone size, and femoral strength in men and women. Osteoporos Int. 2012;23:155–62. This study provided information on bone strength, supporting the concept that men and women fracture at approximately the same absolute bone mineral density as measured by DXA. PubMedCrossRefPubMedCentral
35.••
Pasco JA, Lane SE, Brennan SL, et al. Fracture risk among older men: osteopenia and osteoporosis defined using cut-points derived from female versus male reference data. Osteoporos Int. 2014;25:857–62. In this study, men who had osteoporotic fractures were likely to have normal bone density by DXA if a female normative database was used for T-score calculation, illustrating a potential practical problem. PubMedCrossRef
36.
Wiemann L, Krueger D, Vallarta-Ast N, et al. Effect of female database use for T-score derivation in men. J Clin Densitom. 2006;10:244–8.CrossRef
37.•
Schousboe JT, Tanner SB, Leslie WD. Definition of osteoporosis by bone density criteria in men: effect of using female instead of male young reference data depends on skeletal site and densitometer manufacturer. J Clin Densitom. 2014;17:301–6. This is a review of the rationale for using a Caucasian female normative database for determining the DXA T-score in men. PubMedCrossRef
38.
Siris ES, Boonen S, Mitchell PJ, et al. What's in a name? What constitutes the clinical diagnosis of osteoporosis? Osteoporos Int. 2012;23:2093–7.PubMedCrossRef
39.••
Siris ES, Adler R, Bilezikian J, et al. The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int. 2014;25:1439–43. This paper provides the rationale for making the diagnosis of osteoporosis in patients who may not have a DXA T-score ≤ -2.5.PubMedCrossRefPubMedCentral
40.
Papaioannou A, Morin S, Cheung AM, et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. Can Med Assoc J. 2010;182:1864–73.CrossRef
41.
Compston J, Bowring C, Cooper A, et al. Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update; 2013. Maturitas. 2013;75:392–6.PubMedCrossRef
42.
Kanis JA, McCloskey EV, Johansson H, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013;24:23–57.PubMedCrossRefPubMedCentral
43.
Kanis JA, Adams J, Borgstrom F, et al. The cost-effectiveness of alendronate in the management of osteoporosis. Bone. 2008;42:4–15.PubMedCrossRef
44.
45.
Smith MR, Egerdie B, Hernandez Toriz N, et al. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med. 2009;361:745–55.PubMedCrossRefPubMedCentral
46.
Studenski SA, Peters KW, Alley DE, et al. The FNIH Sarcopenia Project: rationale, study description, conference recommendations, and final estimates. J Gerontol Ser A Biol Sci Med Sci. 2014;69:547–58.CrossRef
47.
Di Monaco M, Castiglione C, Vallero F, et al. Sarcopenia is more prevalent in men than in women after hip fracture: a cross-sectional study of 591 inpatients. Arch Gerontol Geriatr. 2012;55:e48–52.PubMedCrossRef
48.
Buehring B, Binkley N. Myostatin—the holy grail for muscle, bone, and fat? Curr Osteoporos Rep. 2013;11:407–14.PubMedCrossRef
Metadata
Title
Osteoporosis Diagnosis in Men: The T-Score Controversy Revisited
Authors
Neil Binkley
Robert Adler
John P. Bilezikian
Publication date
01-12-2014
Publisher
Springer US
Published in
Current Osteoporosis Reports / Issue 4/2014
Print ISSN: 1544-1873
Electronic ISSN: 1544-2241
DOI
https://doi.org/10.1007/s11914-014-0242-z

Other articles of this Issue 4/2014

Current Osteoporosis Reports 4/2014 Go to the issue

Skeletal Development (E Schipani and E Zelzer, Section Editors)

microRNAs in Cartilage Development, Homeostasis, and Disease

Therapeutics and Medical Management (E Shane and RA Adler, Section Editors)

Anabolic and Antiresorptive Therapy for Osteoporosis: Combination and Sequential Approaches

Therapeutics and Medical Management (E Shane and RA Adler, Section Editors)

Calcium Use in the Management of Osteoporosis: Continuing Questions and Controversies

Skeletal Development (E Schipani and E Zelzer, Section Editors)

Extracellular Matrix and Developing Growth Plate

Skeletal Development (E Schipani and E Zelzer, Section Editors)

Aerobic Glycolysis in Osteoblasts

Imaging (T Lang and F Wehrli, Section Editors)

Vibrational Spectroscopic Imaging for the Evaluation of Matrix and Mineral Chemistry